Advertisement

Author: Carly Behm

Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants, the devicemaker said April 19.

Outpatient surgery is an inevitable area for spine and orthopedic surgeons to explore. From the potential of innovation to the business outlook for hospitals, here's what five surgeons are saying about outpatient migration in 2022:

Advertisement
Advertisement